Acadia Pharmaceuticals reported $6.68M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 6.68M 1.48M
Adamas Pharmaceuticals ADMS:US 576K 49K
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
ALKERMES ALKS:US 49.56M 3.56M
Alnylam Pharmaceuticals ALNY:US $ 32.66M 2.41M
Biogen BIIB:US $ 511.8M 52.1M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Bristol Myers Squibb BMY:US $ 2291M 160M
Corcept Therapeutics CORT:US $ 1.27M 0.11M
Eisai 4523:JP Y 40621M 1371M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Intercept Pharmaceuticals ICPT:US $ 0.66M 0.04M
Intra Cellular Therapies ITCI:US $ 2M 0.04M
Johnson & Johnson JNJ:US $ 7250M 317M
Moderna Inc MRNA:US 722M 28M
Neurocrine Biosciences NBIX:US $ 4.2M 1.1M
Pfizer PFE:US $ 9931M 2939M
Ptc Therapeutics PTCT:US $ 6.54M 0.82M
Sarepta Therapeutics SRPT:US $ 23.44M 3.93M
Seattle Genetics SGEN:US $ 82.65M 4.56M
Ultragenyx Pharmaceutical RARE:US $ 4.18M 1.04M
Vanda Pharmaceuticals VNDA:US $ 6.8M 0.23M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M
YTE INCY:US $ 34.47M 1.84M
Zogenix ZGNX:US $ 1.29M 0.07M